Ligandrol (LGD-4033) Ultima Pharmaceuticals

£108.00

Ligandrol (LGD-4033) is a non-steroidal SARM from Ultima Pharmaceuticals researched for selective androgen receptor modulation in muscle and bone tissue studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ligandrol (LGD-4033) Ultima Pharmaceuticals
Ligandrol (LGD-4033) Ultima Pharmaceuticals
£108.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Ligandrol Research Overview

Ligandrol (LGD-4033) is a non-steroidal selective androgen receptor modulator (SARM) developed for laboratory research applications investigating muscle and bone tissue responses. This compound from Ultima Pharmaceuticals demonstrates high binding affinity to androgen receptors while exhibiting tissue-selective activity profiles in preclinical models. Researchers at Stroid UK Shop utilise LGD-4033 to examine androgen receptor signalling pathways and anabolic mechanisms in controlled laboratory environments.

Research Applications

Scientists study LGD-4033 to investigate selective androgenic activity in muscle and bone tissue versus prostate tissue in animal models. The compound has advanced through Phase I clinical trials, providing valuable research data for muscle-wasting condition studies and osteoporosis research protocols. Investigators within the Ligandrol research category analyse its oral bioavailability characteristics and tissue selectivity mechanisms. Research teams examining SARM compounds frequently compare LGD-4033’s receptor binding profiles with other selective modulators to understand structural activity relationships. Metabolic researchers investigating anabolic pathways often reference LGD-4033 studies when examining similar mechanisms found in peptide research. Laboratory studies focus on understanding how this compound modulates gene expression patterns related to muscle protein synthesis and bone mineralisation processes.

Research Specifications

LGD-4033 Research Compound Specifications
CAS Registry 1165910-22-4
Molecular Formula C₁₄H₁₂F₆N₂O
Molecular Weight 338.25 g/mol
Storage Conditions Room temperature, protected from moisture
Solubility DMSO, ethanol
Stability Stable under recommended storage conditions

Research Compliance

This Ligandrol (LGD-4033) product from Ultima Pharmaceuticals is manufactured exclusively for in-vitro laboratory research purposes. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must comply with institutional guidelines and local regulations when handling this material. All studies should be conducted by qualified personnel in appropriate laboratory facilities with proper safety protocols.

Related